{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:38:44Z","timestamp":1771007924839,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:00Z","timestamp":1502409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91439123"],"award-info":[{"award-number":["91439123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471075"],"award-info":[{"award-number":["81471075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and Aims<\/jats:title><jats:p>This study aimed to investigate the relationship between circulating soluble C\u2010X\u2010C chemokine ligand 16 (CXCL16) levels and clinical characteristics of gallstone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>93 subjects including 53 subjects with gallstone, 25 subjects with nonalcoholic fatty liver disease (NAFLD), and 40 control subjects were recruited. All gallstone subjects underwent ultrasounds to confirm the gallstone patients. Serum CXCL16 levels and other clinical and biochemical parameters in all subjects were obtained based on standard clinical examination methods. Liver tissues from patients with gallstone undergoing cholecystotomy and healthy subjects were also used to determine the hepatic CXCL16 profiles by IHC staining and real\u2010time quantitative PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Serum CXCL16 levels were significantly increased in patients with gallstone and NAFLD as compared to healthy controls (<jats:italic>P<\/jats:italic> &lt; 0\u00b7001). Hepatic CXCL16 mRNA and protein levels were also significantly increased in gallstone patients following with elevation of hepatic triglycerides and free fatty acid concentration, as compared to those in healthy subjects (<jats:italic>P<\/jats:italic> &lt; 0\u00b7001). Otherwise, serum CXCL16 levels positively correlated with nonalcoholic fatty liver disease (NAFLD), alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma\u2010glutamyl transpeptidase (GGT) and direct bilirubin (<jats:italic>P<\/jats:italic> &lt; 0\u00b705), but negatively with total protein and albumin after adjustment with age and gender. Multiple stepwise regression analyses indicated that CXCL16 was independently associated with AST, NAFLD and albumin (<jats:italic>P<\/jats:italic> &lt; 0\u00b705, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Serum CXCL16 levels are significantly increased in patients with gallstone, and are independently associated with liver injury in Chinese population, suggesting that CXCL16 may be a biomarker of liver injury in subjects with gallstone or NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.1111\/eci.12788","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T12:09:22Z","timestamp":1500466162000},"page":"667-674","source":"Crossref","is-referenced-by-count":7,"title":["Hepatic CXCL16 is increased in gallstone accompanied with liver injury"],"prefix":"10.1111","volume":"47","author":[{"given":"Saisai","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Shi","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Xie","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihui","family":"Shao","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanna","family":"Ye","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuebo","family":"Pan","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-2290","authenticated-orcid":false,"given":"Zhuofeng","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science Wenzhou Medical University Wenzhou China"},{"name":"School of Environmental and Biological Engineering Nanjing University of Technology Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197811302992205"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018849911355"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M700295-JLR200"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/356761"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.4318\/tjg.2010.0128"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.6.2960"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/79738"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.3.1136"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1003465"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.8.5145"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000114565.42679.c6"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202909"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030113"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.2.1055"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i32.4979"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909089235"},{"key":"e_1_2_8_18_1","first-page":"16","article-title":"Plasma lipid profile in gallstone patients from North India","volume":"16","author":"Saraya A","year":"1995","journal-title":"Trop Gastroenterol"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90978-A"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(08)60652-2"},{"key":"e_1_2_8_21_1","first-page":"525a","article-title":"Elevation of alkaline phosphatase during follow\u2010up is an early predictor of hyperbilirubinaemia and of clinical endpoints in primary biliary cirrhosis \u2010 an international study","volume":"62","author":"Lammers WJ","year":"2015","journal-title":"Hepatology"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6346(99)00005-4"},{"key":"e_1_2_8_23_1","first-page":"572a","article-title":"Rising AST\/ALT ratio: an indicator of progression of liver disease in cirrhotic veterans with chronic hepatitis C","volume":"34","author":"Mihas AA","year":"2001","journal-title":"Hepatology"},{"key":"e_1_2_8_24_1","first-page":"547a","article-title":"The degree of elevation of ALT levels in chronic hepatitis C virus infection does indicate the degree of histologic liver injury","volume":"32","author":"Pianko S","year":"2000","journal-title":"Hepatology"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.70"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.643481"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3678"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C000761200"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311660200"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.4.1647"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2011.02473.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087786"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Feci.12788","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/eci.12788","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T09:13:08Z","timestamp":1696237988000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/eci.12788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,11]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1111\/eci.12788"],"URL":"https:\/\/doi.org\/10.1111\/eci.12788","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,11]]}}}